Antifungal prophylaxis and empiric therapy in neutropenic patients.
The present paper is a review of antifungal therapy in neutropenic patients with particular emphasis of itraconazole in fungal opportunistic infections.
Cauwenbergh
G
G
Department of Clinical Research and Development, Janssen Research Foundation, Beerse, Belgium.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000517:prevention & control*; D017964:Itraconazole / Q000627:therapeutic use*; D009181:Mycoses / Q000150:complications / Q000517:prevention & control*; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy*
D017964:Itraconazole